Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Genie29jon Feb 10, 2023 12:34am
63 Views
Post# 35278796

RE:Wow

RE:Wow

I personally have grown my shares by about 35% in the past month. I have a growing optimism things will be very good come summer. 

I am now at an uncomfortable amount of shares for my overall portfolio, but it's hard to think:
1. The device won't come to market soon. They've come soooo far...
2. How The Shiseido "partnership" won't result in something positive. Replicel will win. The results will be positive. If this was a dud, Shiseido would have dropped any/all testing and moved on. They haven't. They are still progressing. Why? Because the product, or an element of RCH-01 works...and they need it 

if Replicel can just start collecting SOME cash, it will be the pot of gold at the end of a looooong dark forest that Lee drug us through. 

This is still a huge gamble, but it's moments like this that can make people rich. Im hoping I'm one of them, along with the rest of the followers on this board. 

<< Previous
Bullboard Posts
Next >>